(Q43664495)

25 November 2017

title

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine (English)

1 reference

25 November 2017

0 references

0 references

9

Perry G

1 reference

25 November 2017

Castellani RJ

1

1 reference

25 November 2017

Harris PL

2

1 reference

25 November 2017

Sayre LM

3

1 reference

25 November 2017

Fujii J

4

1 reference

25 November 2017

Taniguchi N

5

1 reference

25 November 2017

Vitek MP

6

1 reference

25 November 2017

Founds H

7

1 reference

25 November 2017

Atwood CS

8

1 reference

25 November 2017

Smith MA

10

1 reference

25 November 2017

language of work or name

1 reference

1 July 2001

1 reference

Free Radical Biology and Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

31

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

175-180

1 reference

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement of glycation in motoneuron diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Conversion of Amadori product of Maillard reaction to Nepsilon-(carboxymethyl)lysine in alkaline condition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Protein Aging by Carboxymethylation of Lysines Generates Sites for Divalent Metal and Redox Active Copper Binding: Relevance to Diseases of Glycoxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Redox metals and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Early AGEing and Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900570-6

7 January 2021

10.1016/S0891-5849(01)00570-6

Identifiers

DOI

1 reference

25 November 2017

1 reference